Trial Profile
A phase II trial of weekly docetaxel (Taxotere) for patients with relapsed ovarian cancer who have previously received paclitaxel
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 30 Jun 2016 New trial record